Correcting Posterior Paraspinal Muscle Computed Tomography Density for Intravenous Contrast Material Independent of Sex and Vascular Phase.

Abstract

Intravenous contrast poses challenges to computed tomography (CT) muscle density analysis. We developed and tested corrections for contrast-enhanced CT muscle density to improve muscle analysis and the utility of CT scans for the assessment of myosteatosis. Using retrospective images from 240 adults who received routine abdominal CT imaging from March to November 2020 with weight-based iodine contrast, we obtained paraspinal muscle density measurements from noncontrast (NC), arterial, and venous-phase images. We used a calibration sample to develop 9 different mean and regression-based corrections for the effect of contrast. We applied the corrections in a validation sample and conducted equivalence testing. We evaluated 140 patients (mean age 52.0y [SD: 18.3]; 60% female) in the calibration sample and 100 patients (mean age 54.8y [SD: 18.9]; 60% female) in the validation sample. Contrast-enhanced muscle density was higher than NC by 8.6HU (SD: 6.2) for the arterial phase (female, 10.4HU [SD: 5.7]; male, 6.0HU [SD:6.0]) and by 6.4HU [SD:8.1] for the venous phase (female, 8.0HU [SD: 8.6]; male, 4.0HU [SD: 6.6]). Corrected contrast-enhanced and NC muscle density was equivalent within 3HU for all correctionns. The -7.5HU correction, independent of sex and phase, performed well for arterial (95% CI: -0.18, 1.80HU) and venous-phase data (95% CI: -0.88, 1.41HU). Our validated correction factor of -7.5HU renders contrast-enhanced muscle density statistically similar to NC density and is a feasible rule-of-thumb for clinicians to implement.